Utility of an adverse drug event trigger tool in Veterans Affairs nursing facilities
- PMID: 23395810
- PMCID: PMC3677952
- DOI: 10.4140/TCP.n.2013.99
Utility of an adverse drug event trigger tool in Veterans Affairs nursing facilities
Abstract
Objective: To determine the utility (i.e., positive predictive value [PPV] and time requirement) of an adverse drug event (ADE) trigger tool in Veterans Affairs (VA) nursing facilities and to describe the most common types of potential ADEs detected with the trigger tool.
Design: Retrospective chart review.
Setting/patients: Veterans residing in three VA nursing facilities between September 29, 2010, and October 29, 2010.
Measurement: We used the Institute for Healthcare Improvement-endorsed nursing facility ADE trigger tool, modified to enhance its clinical relevance to detect potential ADEs. Electronic medical records were screened to identify residents with one or more abnormal laboratory values specified in the trigger tool.
Main outcome measures: A potential ADE was defined as the concurrent administration of medication that could cause the abnormal laboratory value. An overall PPV, or proportion of residents with an abnormal laboratory value who had a potential ADE, and average time required to complete each trigger tool assessment, were calculated.
Results: Among 321 veterans, 50.5% (n = 162) had at least one abnormal laboratory value contained in the trigger tool. Ninety-nine potential ADEs involving 146 medications were detected in 65 veterans. The overall PPV of the ADE trigger tool was 40.1% (65/162), and the average time to complete resident assessments was 8.8 (standard deviation ± 5.7) minutes. The most common potential ADEs were acute kidney injury (n = 30 residents), hypokalemia (n = 18), hypoglycemia (n = 13), and hyperkalemia (n = 10).
Conclusions: The modified nursing facility trigger tool was shown to be an effective and efficient method for detecting potential ADEs.
Similar articles
-
Identifying Medication-Related Adverse Drug Events in Nursing Facilities in East Texas.Consult Pharm. 2016;31(8):436-9. doi: 10.4140/TCP.n.2016.436. Consult Pharm. 2016. PMID: 27535078
-
Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.Ann Pharmacother. 2013 Nov;47(11):1414-9. doi: 10.1177/1060028013500939. Ann Pharmacother. 2013. PMID: 24285758
-
Establishing a trigger tool based on global trigger tools to identify adverse drug events in obstetric inpatients in China.BMC Health Serv Res. 2024 Jan 15;24(1):72. doi: 10.1186/s12913-023-10449-z. BMC Health Serv Res. 2024. PMID: 38225629 Free PMC article. Review.
-
Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.Eur J Cancer. 2015 Feb;51(3):427-35. doi: 10.1016/j.ejca.2014.12.002. Epub 2014 Dec 27. Eur J Cancer. 2015. PMID: 25549531
-
Comprehensive Literature Review of Factors Influencing Medication Safety in Nursing Homes: Using a Systems Model.J Am Med Dir Assoc. 2017 Jun 1;18(6):470-488. doi: 10.1016/j.jamda.2016.12.069. Epub 2017 Feb 24. J Am Med Dir Assoc. 2017. PMID: 28242191 Review.
Cited by
-
Adverse drug events in Chinese elder inpatients: a retrospective review for evaluating the efficiency of the Global Trigger Tool.Front Med (Lausanne). 2023 Sep 28;10:1232334. doi: 10.3389/fmed.2023.1232334. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37841014 Free PMC article.
-
Predicting Hepatotoxicity Associated with Low-Dose Methotrexate Using Machine Learning.J Clin Med. 2023 Feb 17;12(4):1599. doi: 10.3390/jcm12041599. J Clin Med. 2023. PMID: 36836131 Free PMC article.
-
The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings.Adv Ther. 2023 Mar;40(3):1204-1223. doi: 10.1007/s12325-022-02420-x. Epub 2023 Jan 18. Adv Ther. 2023. PMID: 36652174 Free PMC article.
-
Predicting adverse drug events in older inpatients: a machine learning study.Int J Clin Pharm. 2022 Dec;44(6):1304-1311. doi: 10.1007/s11096-022-01468-7. Epub 2022 Sep 17. Int J Clin Pharm. 2022. PMID: 36115909
-
Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis.PLoS One. 2021 May 26;16(5):e0252161. doi: 10.1371/journal.pone.0252161. eCollection 2021. PLoS One. 2021. PMID: 34038474 Free PMC article.
References
-
- Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
-
- Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107–16. - PubMed
-
- Gurwitz JH, Field TS, Judge J, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med. 2005;118:251–58. - PubMed
-
- Handler SM, Wright RM, Ruby CM, et al. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother. 2006;4:264–72. - PubMed
-
- Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997;157:2089–96. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- R01 AG027017/AG/NIA NIH HHS/United States
- R01 HS018721/HS/AHRQ HHS/United States
- R01 HS017695/HS/AHRQ HHS/United States
- R01HS018721/HS/AHRQ HHS/United States
- K12 HS019461/HS/AHRQ HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- T32AG021885/AG/NIA NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
- R56AG027017/AG/NIA NIH HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- R01NS010135/NS/NINDS NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- K12HS019461/HS/AHRQ HHS/United States
- R01HS017695/HS/AHRQ HHS/United States
- R01 NR010135/NR/NINR NIH HHS/United States
- R56 AG027017/AG/NIA NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
